This report is an update on the earlier report: Cell-based Assays:
Technologies and Global Markets. It reviews global markets for
cell-based assays and new developments and forecasts trends for use of
these assays for drug discovery, safety and toxicology through 2021. The
report includes important assays, technologies and the latest
developments and market share by assay type and company, with a special
emphasis on the U.S. market. Statistical information on the types of
cancers prevalent worldwide is also included.

The report also includes current issues and trends affecting the
industry, costs and factors influencing demand. It covers products in
development, new technologies, trends, and alliances and mergers. The
report offers market data by segment and region. It also provides market
trends with respect to drivers, restraints and opportunities.

Report Includes

An overview of the global markets and related technologies for
cell-based assays.

Analyses of global market trends, with data from 2015 and 2016, and
projections of compound annual growth rates (CAGRs) through 2021.

Examinations of major issues involved in the research and development
(R&D) of more effective cell-based approaches, for drug discovery and
absorption, distribution, metabolism, and excretion (ADME)/ toxicity
assays in development and in use.

The current market status of cell-based assays in terms of strengths,
weaknesses, opportunities and threats facing various assays and
developments already on the market.

Discussion of current issues and trends affecting the industry, and
costs and other factors influencing demand.